PAVMED INC.
One Grand Central Place, Suite 4600
New York, New York 10165
October 15, 2018
Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
| Re: | PAVmed Inc. | |
| Registration Statement on Form S-3 | ||
| Originally Filed October 5, 2018 | ||
| File No. 333-227718 |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. (the “Company”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-227718), so that such Registration Statement will become effective at 4:30 p.m. Eastern Time on Wednesday, October 17, 2018, or as soon thereafter as practicable.
| Sincerely, | ||
| PAVMED INC. | ||
| By: | /s/ Lishan Aklog, M.D. | |
| Name: | Lishan Aklog, M.D. | |
| Title: | Chairman and Chief Executive Officer | |
